Q1 2025 Earnings Estimate for Centene Co. (NYSE:CNC) Issued By Zacks Research

Centene Co. (NYSE:CNC) – Equities researchers at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for Centene in a research report issued to clients and investors on Tuesday, September 17th. Zacks Research analyst K. Dey now anticipates that the company will post earnings of $2.69 per share for the quarter, down from their prior forecast of $2.72. The consensus estimate for Centene’s current full-year earnings is $6.82 per share. Zacks Research also issued estimates for Centene’s Q2 2025 earnings at $1.85 EPS, Q4 2025 earnings at $0.99 EPS, FY2025 earnings at $7.34 EPS, Q1 2026 earnings at $2.99 EPS, Q2 2026 earnings at $2.08 EPS and FY2026 earnings at $8.14 EPS.

Centene (NYSE:CNC) last announced its quarterly earnings data on Friday, July 26th. The company reported $2.42 earnings per share for the quarter, missing the consensus estimate of $2.44 by ($0.02). Centene had a return on equity of 14.45% and a net margin of 1.79%. The company had revenue of $39.84 billion for the quarter, compared to analysts’ expectations of $36.83 billion. During the same quarter in the previous year, the company earned $2.10 earnings per share. The company’s revenue was up 5.9% on a year-over-year basis.

Other research analysts have also recently issued research reports about the company. Stephens reissued an “equal weight” rating and set a $78.00 price target on shares of Centene in a research report on Monday, August 5th. TD Cowen boosted their target price on Centene from $80.00 to $89.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Centene from $82.00 to $87.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Wells Fargo & Company cut their target price on shares of Centene from $93.00 to $91.00 and set an “overweight” rating on the stock in a research note on Friday, September 13th. Finally, Jefferies Financial Group cut shares of Centene from a “buy” rating to a “hold” rating and decreased their price target for the stock from $83.00 to $69.00 in a research report on Wednesday, July 24th. Seven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $85.58.

Centene Stock Up 1.2 %

Shares of NYSE CNC opened at $76.32 on Thursday. The stock has a market capitalization of $40.73 billion, a PE ratio of 15.17, a P/E/G ratio of 0.99 and a beta of 0.48. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.64. The firm has a fifty day moving average of $74.16 and a 200-day moving average of $73.52. Centene has a 52-week low of $63.45 and a 52-week high of $81.42.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in CNC. Rise Advisors LLC acquired a new position in shares of Centene in the 1st quarter valued at about $25,000. WR Wealth Planners LLC lifted its holdings in shares of Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after purchasing an additional 137 shares during the last quarter. Chris Bulman Inc acquired a new stake in Centene in the second quarter worth $33,000. Riverview Trust Co increased its holdings in shares of Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after acquiring an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Centene in the second quarter valued at approximately $36,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.